Life Science Success

Send us Fan Mail
In this episode of the Life Science Success Podcast my guest is Megha Sinha. The founder and CEO of Kamet Consulting Group LLC, she brings 17+ years of experience advising global pharma and life sciences on regulatory operations, quality, and large-scale transformation, including senior leadership at PwC solving complex regulatory, supply chain, and lifecycle management challenges.

00:00 Show Introduction
00:30 Meet Megha Sinha
01:18 Engineering Into Life Sciences
03:29 First FDA Audit Lessons
04:29 PwC Shaping Consulting
07:27 Three Career Pivots
12:22 Why Found Kamet
17:24 Mission And Programs
19:27 Global Regulatory Depth
24:57 Transformation In Practice
30:24 Scaling Team And Tech
35:14 Leadership Inspiration Concerns
40:48 AI Beyond Automation
44:27 Closing And Next Steps

Send us Fan Mail
In this episode of the Life Science Success Podcast my guest is Ian Crone. He is the VP Regulatory strategy and growth at ArisGlobal and a global life sciences leader known for RIM, UDI, IDMP, and data migration expertise, inspiring teams to deliver compliant, client-centric solutions.
00:00 Show Intro
00:30 Meet Ian Crone
01:12 From Lab Bench Up
03:07 Regulatory Deja Vu
05:15 IDMP Explained
07:39 Single Source Truth
10:38 Why Migrations Fail
14:40 Interpretive Drift Risk
15:56 Best of Breed Debate
21:27 Compliance Clock Ticking
23:59 AI Needs Humans
26:00 Why ArisGlobal
27:33 Sportify Overlay Approach
28:49 Data Cortex XDI
31:10 IDMP Data For AI
32:31 AI As Experimentation
33:54 Leading Under Pressure
36:20 Mentorship Lessons
37:05 Personal Motivation Story
39:23 AI Hype Versus Readiness
42:15 Human In The Loop
44:42 Breaking Silos Wins
47:02 Closing And Next Steps

Send us Fan Mail
In this episode of the Life Science Success Podcast my guest is Jennifer Vavala, Founder & Principal at AlignPoint Partners. With more than 27 years in pharma, medical device, and diagnostics leading QA/QC in complex regulated organizations, she focuses on quality systems, inspection readiness, and operational delivery, and developed the Operational Stability Recalibration framework to help leaders rebalance escalating mandates with operating capacity before compliance or delivery risks surface.

00:00 Intro
00:30 Meet Jennifer Vavala
01:39 Microbiology Origins
04:13 Capacity Not Capability
08:43 Across Regulated Sectors
12:25 AlignPoint Partners Mission
13:15 Operational Stability Framework
18:02 Early Warning Signals
19:52 Inspection Readiness Reality
23:55 Executives And Regulators
32:37 Quality Leadership Future
36:15 Inspiration Concerns Excitement
39:39 Wrap Up And Where To Connect
40:19 Outro

Send us Fan Mail
In this episode of the Life Science Success Podcast my guest is Dean Erhardt, President and CEO at D2 Solutions. He brings more than 20 years of experience across pharmaceuticals and consumer products, with expertise in support program development, distribution, and specialty product management, and has worked with over 100 pharmaceutical, biotech, and medical device manufacturers as well as many small and midsized organizations on commercial operations, strategy, and national accounts.

00:00 Intro
00:34 Dean's career: HMO, Cardinal Health, Express Scripts
03:00 Founding D2 Solutions in 2008
04:00 Pricing strategy and middlemen taking 50–70% of revenue
08:00 What separates successful commercialization from failure
10:00 D2's three pillars: distribution, reimbursement, patient services
15:00 Pharmaceutical support programs for specialty medications
16:00 D2's digital patient engagement platform in action
21:00 Resource challenges for small and mid-sized pharma
22:00 Retail deserts and the rise of direct-to-consumer models
24:00 National accounts strategy and long-term payer relationships
26:00 When to engage D2 and cleaning up commercialization missteps
28:00 The prior authorization crisis
31:00 Leadership advice: one vision, said a million times
32:00 AI, remote surgery, and the future of care
34:00 Looming shortage of 3.9 million healthcare workers
36:00 Concerns: aging population, lost patients, NIH funding
37:00 Technology accelerating drug approvals
38:00 Outro

Send us Fan Mail
Jesse Mendelsohn and Michael Grosberg from Model N discuss why U.S. pricing complexity is spreading globally, the collapse of the PBM rebate model, what's really driving the pharmaceutical manufacturing boom, and why direct-to-consumer discount programs won't solve America's drug access problem.

00:00 Introduction to Life Science Success Podcast
00:34 Pressing Issues in Pharmaceutical Manufacturing
00:51 Introducing the Experts from Model N
03:08 Understanding International Reference Pricing
04:14 Impact of US Pricing on Global Drug Launches
09:26 Challenges with Pharmacy Benefit Managers
16:29 Domestic Manufacturing Boom in Pharmaceuticals
23:08 AI in Drug Discovery and Personalized Medicine
29:03 Access and Policy Discussion
30:01 Direct to Consumer Pricing
31:32 TrumpRx Overview
33:11 Compliance Challenges
38:30 Pharmaceutical Revenue Management
41:38 AI in Life Sciences
48:35 Future of Life Sciences
50:45 Concerns and Challenges
53:52 Excitement in Current Work
55:54 Conclusion and Final Thoughts